157 related articles for article (PubMed ID: 28782861)
1. Histone deacetylase 11 suppresses p53 expression in pituitary tumor cells.
Wang W; Fu L; Li S; Xu Z; Li X
Cell Biol Int; 2017 Dec; 41(12):1290-1295. PubMed ID: 28782861
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
4. HDAC11 is a novel drug target in carcinomas.
Deubzer HE; Schier MC; Oehme I; Lodrini M; Haendler B; Sommer A; Witt O
Int J Cancer; 2013 May; 132(9):2200-8. PubMed ID: 23024001
[TBL] [Abstract][Full Text] [Related]
5. HDAC11 mediates the ubiquitin-dependent degradation of p53 and inhibits the anti-leukemia effect of PD0166285.
Zhou Z; Zhong L; Chu X; Wan P; Dan W; Shao X; Chen S; Zhang Z; Lu Y; Liu B
Med Oncol; 2023 Oct; 40(11):325. PubMed ID: 37805625
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity.
Harms KL; Chen X
Cancer Res; 2007 Apr; 67(7):3145-52. PubMed ID: 17409421
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylases induces formation of multipolar spindles and subsequent p53-dependent apoptosis in nasopharyngeal carcinoma cells.
Yan M; Qian YM; Yue CF; Wang ZF; Wang BC; Zhang W; Zheng FM; Liu Q
Oncotarget; 2016 Jul; 7(28):44171-44184. PubMed ID: 27283770
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina.
Wallace DM; Cotter TG
J Neurosci Res; 2009 Mar; 87(4):887-905. PubMed ID: 18951482
[TBL] [Abstract][Full Text] [Related]
10. Histone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation.
Deng Z; Liu X; Jin J; Xu H; Gao Q; Wang Y; Zhao J
Int J Biol Sci; 2016; 12(11):1298-1308. PubMed ID: 27877082
[No Abstract] [Full Text] [Related]
11. HDAC11 regulates interleukin-13 expression in CD4+ T cells in the heart.
Yuan L; Chen X; Cheng L; Rao M; Chen K; Zhang N; Meng J; Li M; Yang LT; Yang PC; Wang X; Song J
J Mol Cell Cardiol; 2018 Sep; 122():1-10. PubMed ID: 30063898
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
13. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway.
de Conti A; Tryndyak V; Koturbash I; Heidor R; Kuroiwa-Trzmielina J; Ong TP; Beland FA; Moreno FS; Pogribny IP
Carcinogenesis; 2013 Aug; 34(8):1900-6. PubMed ID: 23568954
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylases specifically down-regulate p53-dependent gene activation.
Juan LJ; Shia WJ; Chen MH; Yang WM; Seto E; Lin YS; Wu CW
J Biol Chem; 2000 Jul; 275(27):20436-43. PubMed ID: 10777477
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells.
Gatti L; Benedetti V; De Cesare M; Corna E; Cincinelli R; Zaffaroni N; Zunino F; Perego P
J Inorg Biochem; 2012 Aug; 113():94-101. PubMed ID: 22717676
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation.
Shan X; Fu YS; Aziz F; Wang XQ; Yan Q; Liu JW
PLoS One; 2014; 9(12):e115401. PubMed ID: 25521755
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway.
Li LH; Zhang PR; Cai PY; Li ZC
Biomed Pharmacother; 2016 Aug; 82():161-6. PubMed ID: 27470351
[TBL] [Abstract][Full Text] [Related]
19. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone deacetylase 11 promotes human liver cancer cell apoptosis.
Gong D; Zeng Z; Yi F; Wu J
Am J Transl Res; 2019; 11(2):983-990. PubMed ID: 30899397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]